SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-054617
Filing Date
2022-05-02
Accepted
2022-05-02 16:01:04
Documents
4
Period of Report
2022-06-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm223570-1_def14a.htm DEF 14A 820260
2 GRAPHIC sg_jackakhattarnew1-bw.jpg GRAPHIC 6383
3 GRAPHIC tm223570d1-px_superpg14c.jpg GRAPHIC 491739
4 GRAPHIC tm223570d1-px_superpg24c.jpg GRAPHIC 459556
  Complete submission text file 0001104659-22-054617.txt   2140509
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35518 | Film No.: 22881784
SIC: 2834 Pharmaceutical Preparations